ArticleResearch square2025

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants.

Alexander C Conley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.